Wellbiotec Co., Ltd. (KRX:010600)

Wellbiotec Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,274	7,327	10,084	10,414	3,909	1,748
Short-Term Investments	1,050	1,050	9,110	1,050	1,050	6,050
Trading Asset Securities	-	-	2,189	3,212	4,014	502.89
Cash & Short-Term Investments	6,324	8,377	21,384	14,676	8,974	8,301
Cash Growth	-31.39%	-60.82%	45.70%	63.55%	8.10%	-63.94%
Accounts Receivable	7,658	9,762	10,214	20,008	21,334	13,429
Other Receivables	350.64	344.13	858.69	4,460	3,882	362.79
Receivables	8,008	11,145	11,422	24,668	26,416	13,792
Inventory	-	-	1,663	1,063	1,789	5,403
Prepaid Expenses	-	2,407	1,141	2,759	3,031	1,348
Other Current Assets	4,225	2,041	3,137	3,465	6,142	786.08
Total Current Assets	18,558	23,970	38,747	46,632	46,352	29,629
Property, Plant & Equipment	1,407	2,034	4,046	1,756	1,872	2,405
Long-Term Investments	3,453	4,620	16,010	4,978	6,610	17,203
Goodwill	-	-	-	2,942	3,604	5,443
Other Intangible Assets	592.53	224.53	233.75	1,225	1,390	1,364
Long-Term Deferred Tax Assets	68.91	74.71	120.39	456.33	334.7	-
Other Long-Term Assets	1,060	1,025	1,084	1,296	79,221	14,876
Total Assets	25,139	31,948	60,241	59,285	139,383	70,921
Accounts Payable	-	2,259	7,074	9,135	7,265	5,009
Accrued Expenses	-	1,807	1,901	344.24	395.74	-
Short-Term Debt	-	-	5,475	4,914	22,657	31,357
Current Portion of Long-Term Debt	-	-	60	60	60	93.32
Current Portion of Leases	706.33	809.65	1,031	628.02	747.93	937.34
Current Income Taxes Payable	216.6	439.9	66.25	1,305	674.17	185.45
Other Current Liabilities	8,098	5,411	4,963	6,253	65,304	4,157
Total Current Liabilities	9,021	10,726	20,570	22,640	97,104	41,740
Long-Term Debt	-	-	60	120	180	7,604
Long-Term Leases	572.51	966.19	1,637	483.06	554.93	1,080
Pension & Post-Retirement Benefits	39.65	-	540.09	625.67	879.35	999.91
Other Long-Term Liabilities	1.9	70.95	214.36	114.16	3,636	7.13
Total Liabilities	9,635	11,764	23,021	23,983	102,354	51,430
Common Stock	45,462	45,462	45,462	33,216	29,339	22,655
Additional Paid-In Capital	157,404	157,043	154,093	99,026	184,056	136,842
Retained Earnings	-190,050	-185,362	-167,094	-102,063	-181,327	-145,428
Treasury Stock	-0.67	-0.67	-0.67	-0.67	-0.67	-0.67
Comprehensive Income & Other	2,689	3,041	5,546	4,590	4,477	4,918
Total Common Equity	15,504	20,183	38,006	34,769	36,544	18,986
Minority Interest	0.55	0.97	-786.43	534.24	485.38	504.14
Shareholders' Equity	15,504	20,184	37,220	35,303	37,029	19,491
Total Liabilities & Equity	25,139	31,948	60,241	59,285	139,383	70,921
Total Debt	1,279	1,776	8,263	6,205	24,200	41,071
Net Cash (Debt)	5,046	6,601	13,121	8,471	-15,226	-32,770
Net Cash Growth	-31.13%	-49.69%	54.90%	-	-	-
Net Cash Per Share	63.91	83.35	165.67	131.69	-275.06	-750.04
Filing Date Shares Outstanding	90.92	90.92	90.92	66.43	58.68	45.31
Total Common Shares Outstanding	90.92	90.92	90.92	66.43	58.68	45.31
Working Capital	9,538	13,243	18,177	23,992	-50,752	-12,110
Book Value Per Share	170.52	221.98	418.00	523.38	622.80	419.04
Tangible Book Value	14,911	19,959	37,772	30,601	31,550	12,179
Tangible Book Value Per Share	164.00	219.51	415.43	460.64	537.70	268.79
Land	4.7	4.7	4.7	4.7	4.7	4.7
Buildings	5.06	5.06	5.06	5.06	5.06	5.06
Machinery	456.67	446.41	720.48	719.04	624.81	576.6
Construction In Progress	-	-	23.93	126	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.